Skip to content
Disclosery

Lunate Capital Ltd

Follow

13F filer, CIK 2056786, AL MARYAH ISLAND, ABU DHABI, United Arab Emirates

Lunate Capital Ltd reported $178,071,082 across 6 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-07-17.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001011438-25-000357

Period
2025-06-30
Reported value
$178M
Holdings
6
Top 10 weight
100%
New
2
Sold out
0

Part of the filer group Lunate Capital Ltd

How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
IOTnew+22,751$905K
RVMDWnew+450,000$118K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

None.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0001011438-25-000357, largest first. % of portfolio is the value over $178,071,082, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 2,196,200 shares; 2025Q2: 2,196,200 shares 2,196,200$80.8M45.37%0Timeline
SAILSAILPOINT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 3,000,000 shares; 2025Q2: 3,000,000 shares 3,000,000$68.6M38.51%0Timeline
LINELINEAGE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 600,000 shares; 2025Q2: 600,000 shares 600,000$26.1M14.66%0Timeline
NMRANEUMORA THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 2,124,143 shares; 2025Q2: 2,124,143 shares 2,124,143$1.56M0.87%0Timeline
IOTSAMSARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not reported; 2025Q2: 22,751 shares 22,751$905K0.51%newTimeline
RVMDWREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not reported; 2025Q2: 450,000 shares 450,000$118K0.07%newTimeline

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001011438-25-000357 base2025-07-17acceptance time not in the bulk data set